EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Faecal volatile organic compounds differ according to inflammatory bowel disease sub‐type, severity, and response to treatment in paediatric patients

Salma Belnour, Rachael Slater, Kukatharmini Tharmaratnam, Marcus Karl-Heinz Auth, Rafeeq Muhammed, Christine Spray, Duolao Wang, Umer Zeeshan Ijaz, Chris Probert, Stephen Allen

United European Gastroenterology Journal · 2024-07 · 12 (6) · 780-792

DOI: 10.1002/ueg2.12603 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift United European Gastroenterology Journal, online erschienen am 22.06.2024. Verfasst von Salma Belnour und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK. Hauptthemen laut MEDLINE: Volatile Organic Compounds, Feces, Colitis, Ulcerative, Severity of Illness Index. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research under its Research for Patient Benefit Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Faecal volatile organic compounds (VOCs) differ with disease sub‐type and activity in adults with established inflammatory bowel disease (IBD) taking therapy.

Objective

To describe patterns of faecal VOCs in children newly presented with IBD according to disease sub‐type, severity, and response to treatment.

Methods

Children presenting with suspected IBD were recruited from three UK hospitals. Children in whom IBD was diagnosed were matched with a non‐IBD child for age, sex, and recruitment site. Faecal VOCs were characterised by gas chromatography–mass spectrometry at presentation and 3 months later in children with IBD.

Results

In 132 case/control pairs, median (inter‐quartile range) age in IBD was 13.3 years (10.2–14.7) and 38.6% were female. Compared with controls, the mean abundance of 27/62 (43.6%) faecal VOCs was statistically significantly decreased in Crohn's disease (CD), ulcerative colitis (UC) or both especially amongst ketones/diketones, fatty acids, and alcohols ( p < 0.05). Short‐chain, medium chain, and branched chain fatty acids were markedly reduced in severe colitis ( p < 0.05). Despite clinical improvement in many children with IBD, the number and abundance of almost all VOCs did not increase following treatment, suggesting persistent dysbiosis. Oct‐1‐en‐3‐ol was increased in CD ( p = 0.001) and UC ( p = 0.012) compared with controls and decreased following treatment in UC ( p = 0.01). In CD, propan‐1‐ol was significantly greater than controls ( p < 0.001) and extensive colitis ( p = 0.001) and fell with treatment ( p = 0.05). Phenol was significantly greater in CD ( p < 0.001) and fell with treatment in both CD ( p = 0.02) and UC ( p = 0.01).

Conclusion

Characterisation of faecal VOCs in an inception cohort of children with IBD reveals patterns associated with diagnosis, disease activity, and extent. Further work should investigate the relationship between VOCs and the microbiome in IBD and their role in diagnosis and disease monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Volatile Organic CompoundsFecesColitis, UlcerativeSeverity of Illness IndexCrohn DiseaseHumansFemaleMaleChildCase-Control StudiesAdolescentGas Chromatography-Mass SpectrometryTreatment OutcomeUnited KingdomInflammatory Bowel Diseases

Stichwörter der Autor:innen

Crohn's diseaseGC/MSIBDVOCschildrenfaecal volatile organic compoundsgas chromatography–mass spectrometryulcerative colitis

Substanzen

Volatile Organic Compounds

Autor:innen und Institutionen

  • Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.
  • Department of Molecular & Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, Liverpool, UK.
  • Department of Health Data Science, Institute of Systems, Molecular and Integrative Biology, Liverpool, UK.
  • Paediatric Gastroenterology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
  • Gastroenterology and Nutrition, Birmingham Children's Hospital, Birmingham, UK.
  • Paediatric Gastroenterology, Bristol Royal Hospital for Children, Bristol, UK.

Förderung

  • National Institute for Health and Care Research under its Research for Patient Benefit Programme

Zitieren

APA

Belnour, S., Slater, R., Tharmaratnam, K., Karl-Heinz Auth, M., Muhammed, R., Spray, C., Wang, D., Zeeshan Ijaz, U., Probert, C., & Allen, S. (2024). Faecal volatile organic compounds differ according to inflammatory bowel disease sub‐type, severity, and response to treatment in paediatric patients. United European Gastroenterology Journal, 12(6), 780-792. https://doi.org/10.1002/ueg2.12603

Vancouver

Belnour S, Slater R, Tharmaratnam K, Karl-Heinz Auth M, Muhammed R, Spray C, et al. Faecal volatile organic compounds differ according to inflammatory bowel disease sub‐type, severity, and response to treatment in paediatric patients. United European Gastroenterology Journal. 2024;12(6):780-792. doi:10.1002/ueg2.12603

BibTeX
@article{Belnour2024,
  author = {Belnour, Salma and Slater, Rachael and Tharmaratnam, Kukatharmini and Karl-Heinz Auth, Marcus and Muhammed, Rafeeq and Spray, Christine and Wang, Duolao and Zeeshan Ijaz, Umer and Probert, Chris and Allen, Stephen},
  title = {Faecal volatile organic compounds differ according to inflammatory bowel disease sub‐type, severity, and response to treatment in paediatric patients},
  journal = {United European Gastroenterology Journal},
  year = {2024},
  volume = {12},
  number = {6},
  pages = {780--792},
  doi = {10.1002/ueg2.12603}
}
Kostenlos starten →